XML 19 R13.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Other Receivables | 3 Months Ended
--- | ---
Mar. 31, 2024
Other Receivables, Net, Current [Abstract] |
Other Receivables | 6. Other Receivables Contemporaneous with the Company’s New Drug Application, or NDA, submission to the U.S. Food and Drug Administration for revumenib, it was required to pay a $6.1 million refundable fee under the Prescription Drug User Fee Act, or PDUFA. The $6.1 million payment was made in January 2024.

X
- Definition Other Receivables [Text Block] + References No definition available. + Details
Name: | sndx_OtherReceivablesTextBlock
Namespace Prefix: | sndx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OtherReceivablesNetCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration